Understanding Why Constipation Occurs with GLP-1 Medications
When you take Ozempic or any semaglutide medication, you're working with a drug that mimics a hormone already present in your body. GLP-1 (glucagon-like peptide-1) does more than regulate blood sugar—it also talks directly to your digestive system. The medication binds to receptors throughout your gut, and that's where things get interesting for your bowel movements.
One of the primary mechanisms behind semaglutide's effects is delayed gastric emptying. In simple terms, your stomach takes longer to pass its contents into your intestines. This isn't an accident—it's by design. Slower digestion helps you feel fuller longer, which supports the medication's weight management goals. However, when food lingers in your digestive tract longer than usual, more water gets absorbed from that material. The result? Harder, drier stools that are tougher to pass.
Research on GLP-1 receptor activity in the gut has shown that these receptors also influence how your intestines handle fluid. When digestion slows down, your colon has more time to reabsorb water from waste. That extra water absorption contributes directly to constipation symptoms. Understanding this mechanism helps explain why the side effect shows up early in treatment and why it affects some people more than others.